title: Oral low-dose methotrexate (MTX) to be efficient in refractory rheumatoid arthritis and adult-onset Still's disease.
authors.forename: S
authors.initials: S
authors.lastname: Kenouch
authors.forename: H
authors.initials: H
authors.lastname: Fessi
authors.forename: J P
authors.initials: JP
authors.lastname: Méry
authors.forename: N
authors.initials: N
authors.lastname: Belmatoug
authors.forename: M F
authors.initials: MF
authors.lastname: Kahn
mesh_terms: D000284:Administration, Oral; D000328:Adult; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000139:chemically induced*
chemical_list: D008727:Methotrexate